Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia.

No Thumbnail Available

Date

2021-03-26

Authors

Carbonell, Raquel
Moreno, Gerard
Martín-Loeches, Ignacio
Gomez-Bertomeu, Frederic
Sarvisé, Carolina
Gómez, Josep
Bodí, María
Díaz, Emili
Papiol, Elisabeth
Trefler, Sandra

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Background: Procalcitonin (PCT) and C-Reactive protein (CRP) are well-established sepsis biomarkers. The association of baseline PCT levels and mortality in pneumonia remains unclear, and we still do not know whether biomarkers levels could be related to the causative microorganism (GPC, GNB). The objective of this study is to address these issues. Methods: a retrospective observational cohort study was conducted in 184 Spanish ICUs (2009-2018). Results: 1608 patients with severe influenza pneumonia with PCT and CRP available levels on admission were included, 1186 with primary viral pneumonia (PVP) and 422 with bacterial Co-infection (BC). Those with BC presented higher PCT levels (4.25 [0.6-19.5] versus 0.6 [0.2-2.3]ng/mL) and CRP (36.7 [20.23-118] versus 28.05 [13.3-109]mg/dL) as compared to PVP (p

Description

MeSH Terms

DeCS Terms

CIE Terms

Keywords

C-Reactive protein, Gram negative bacilli, Gram-positive cocci, mortality, pneumonia, procalcitonin

Citation